HP Microfluidics Fab Receives $50M CHIPS Act Award

The CHIPS and Science Act has approved an award for Rogue Valley Microdevices to enhance its Corvallis fab, resulting in the creation of 100 new manufacturing jobs. This fab, which is an integral part of HP's lab-to-fab ecosystem, plays a crucial role in supporting both research and commercial manufacturing activities.

While the specific details regarding the project's scope and technical objectives remain undisclosed, the US government has allocated a substantial award of US$6.7 million to Rogue Valley Microdevices. This funding injection is poised to drive innovation and growth within the company's operations.

Building upon HP's expertise in microfluidics and microelectromechanical systems (MEMS), the newly enhanced fab is expected to leverage these technologies for various applications, including printing and advancements in life sciences. The development of improved microfluidic components holds significant promise for applications such as drug discovery, single-cell research, and cell line development.

Collaborating with esteemed institutions like Harvard Medical School, the US Center for Disease Control, and Merck, HP is at the forefront of pioneering advancements in microfluidics. Enrique Lores, the CEO of HP, emphasized the transformative potential of microfluidics in driving innovation across industries, citing its ability to enhance speed, efficiency, and precision in life sciences and technology.

Moreover, the Corvallis campus serves as a hub for startups and entrepreneurs, providing them with essential resources and tools to design and manufacture products in the state of Oregon. This ecosystem fosters a culture of innovation and collaboration, further solidifying Rogue Valley Microdevices' position as a key player in the MEMS industry.